ModerateAntiplatelet agents (low dose) / NSAIDs (analgesic dose)×Selective beta-adrenergic blockers
Updated · Methodology
Mechanism
Acetylsalicylic acid, like all salicylates, is a non-steroidal anti-inflammatory drug (NSAID): it inhibits cyclooxygenase and the formation of prostaglandins (acetylsalicylic acid 100 mg SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.1). According to the acetylsalicylic acid SmPCs, NSAIDs may reduce the antihypertensive effect of beta-blockers by inhibiting vasodilating prostaglandins (acetylsalicylic acid 100 mg and 500 mg SmPCs, AEMPS, section 4.5). The bisoprolol SmPCs also state that NSAIDs may reduce the hypotensive effect of bisoprolol (bisoprolol SmPCs, AEMPS, section 4.5). The elimination routes differ. Half of the bisoprolol dose is converted in the liver to inactive metabolites, and the other half is excreted unchanged in the urine (bisoprolol SmPC, AEMPS, section 5.2). Acetylsalicylic acid is converted to salicylic acid, which the liver metabolises, and the kidneys excrete the metabolites (acetylsalicylic acid 100 mg SmPC, AEMPS, section 5.2).
Symptoms
The documents describe no symptoms specific to this combination. A possible sign is a weaker blood-pressure-lowering effect of bisoprolol (bisoprolol and acetylsalicylic acid SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5). Bisoprolol can cause bradycardia, dizziness, cold or numb extremities and hypotension, and in people with bronchial asthma it can increase airway resistance (bisoprolol SmPCs, AEMPS, sections 4.4 and 4.8). Acetylsalicylic acid can cause bleeding, ulceration and perforation in the upper gastrointestinal tract, including cases without previous symptoms. In people with asthma, hay fever, nasal polyps or chronic respiratory insufficiency, it can cause bronchospasm and asthma attacks (acetylsalicylic acid 100 mg SmPC, AEMPS, section 4.4).
Management
The combination is acceptable, but the bisoprolol SmPCs advise caution with non-steroidal anti-inflammatory drugs (NSAIDs), because NSAIDs may reduce the hypotensive effect of bisoprolol (bisoprolol SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5). According to its SmPC, acetylsalicylic acid is an NSAID (acetylsalicylic acid 100 mg SmPC, AEMPS, section 5.1). The statement about a weaker beta-blocker effect does not depend on the dose. The same wording appears in the SmPC of the 100 mg antiplatelet dose and in the SmPC of the 500 mg analgesic form (acetylsalicylic acid 100 mg and 500 mg SmPCs, AEMPS, section 4.5). In people with arterial hypertension, acetylsalicylic acid is prescribed under close medical supervision (acetylsalicylic acid 100 mg SmPC, AEMPS, section 4.4). Acetylsalicylic acid is contraindicated in severe heart failure (acetylsalicylic acid 100 mg SmPC, AEMPS, section 4.3). Stable chronic heart failure is among the indications for bisoprolol (bisoprolol SmPC, AEMPS, section 4.1). Acetylsalicylic acid is contraindicated in bronchial asthma, and bisoprolol in severe bronchial asthma (acetylsalicylic acid 100 mg and bisoprolol SmPCs, AEMPS, section 4.3).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Bisoprolol (nº registro 78903), secciones 4.3, 4.4 y 4.5 (2026)– AEMPS, CIMA, nº registro 78903, revisión 05/2026, secciones 4.3, 4.4 y 4.5
- AEMPS: Ficha técnica: Ácido acetilsalicílico (nº registro 76237), sección 4.5 (2026)– AEMPS, CIMA, nº registro 76237, revisión 08/2026, sección 4.5
- AEMPS: Ficha técnica: Ácido acetilsalicílico, Adiro 100 mg (nº registro 62825) (2026)– AEMPS, CIMA, nº registro 62825 (Adiro 100 mg comprimidos gastrorresistentes EFG), revisión 07/2026, secciones 4.3, 4.4 y 4.5
- AEMPS: Ficha técnica: Ácido acetilsalicílico 500 mg (Aspirina) (nº registro 2011), secciones 4.4 y 4.5 (2026)– AEMPS, CIMA, nº registro 2011, revisión 06/2026, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Bisoprolol, Emconcor COR 5 mg (nº registro 63048), sección 4.5 (2020)– AEMPS, CIMA, nº registro 63048 (Emconcor COR 5 mg comprimidos recubiertos con película, Merck), revisión 11/2020, secciones 4.1 y 4.5